Cell-controlled and spatially arrayed gene delivery from fibrin hydrogels

Biomaterials

Volumn 30, Issue 22, 2009, Pages 3790-3799

  Lei, Pedro ^a   Padmashali, Roshan M ^a   Andreadis, Stelios T ^a,b  

^a the State University of New York   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Cell controlled gene delivery; Fibrin hydrogels; Fibrinolysis; Matrix mediated transfection; Transfection microarrays

Indexed keywords

CELL TRANSFECTION; CROSS CONTAMINATION; DOSE-DEPENDENT MANNER; FIBRIN HYDROGELS; FIBRIN MATRIX; FIBRINOLYSIS; FIBRINOLYTIC INHIBITORS; GENE DELIVERY; GENE TRANSFECTION; IN-CELL; IN-VITRO; IN-VIVO; LIPOFECTAMINE; LIPOPLEX; LOCALIZED GENE DELIVERY; MATRIX-MEDIATED TRANSFECTION; MICROENVIRONMENT; POTENTIAL APPLICATIONS; PROOF OF CONCEPT; TARGET CELLS; TRANSFECTION MICROARRAYS;

BIOMATERIALS; CELL DEATH; GENE TRANSFER; INTERNET; NUCLEIC ACIDS; THREE DIMENSIONAL; TWO DIMENSIONAL;

HYDROGELS;

DNA; FIBRIN; FIBRINOLYTIC AGENT;

ARTICLE; CELL DENSITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; GENE LOCATION; GENE TARGETING; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYDROGEL; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ANIMALS; APROTININ; BIOCOMPATIBLE MATERIALS; CELL LINE; DNA; FIBRIN; GENE TRANSFER TECHNIQUES; HUMANS; HYDROGELS; MATERIALS TESTING; MICE; SERINE PROTEINASE INHIBITORS;

EID: 67349116545     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2009.03.049     Document Type: Article

References (50)

1. Bajaj B., Lei P., and Andreadis S.T. High efficiencies of gene transfer with immobilized recombinant retrovirus: kinetics and optimization. Biotechnol Prog 17 4 (2001) 587-596
2. Bengali Z., Rea J.C., and Shea L.D. Gene expression and internalization following vector adsorption to immobilized proteins: dependence on protein identity and density. J Gene Med 9 8 (2007) 668-678
3. Cohen-Sacks H., Elazar V., Gao J., Golomb A., Adwan H., Korchov N., et al. Delivery and expression of pDNA embedded in collagen matrices. J Control Release 95 2 (2004) 309-320
4. Ochiya T., Takahama Y., Nagahara S., Sumita Y., Hisada A., Itoh H., et al. New delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: the Minipellet. Nat Med 5 6 (1999) 707-710
5. Bajaj B.G., Lei P., and Andreadis S.T. Efficient gene transfer to human epidermal keratinocytes on fibronectin: in vitro evidence for transduction of epidermal stem cells. Mol Ther 11 6 (2005) 969-979
6. Pannier A.K., and Shea L.D. Controlled release systems for DNA delivery. Mol Ther 10 1 (2004) 19-26
7. Segura T., Volk M.J., and Shea L.D. Substrate-mediated DNA delivery: role of the cationic polymer structure and extent of modification. J Control Release 93 1 (2003) 69-84
8. Reinisalo M., Urtti A., and Honkakoski P. Freeze-drying of cationic polymer DNA complexes enables their long-term storage and reverse transfection of post-mitotic cells. J Control Release 110 2 (2006) 437-443
9. Ziauddin J., and Sabatini D.M. Microarrays of cells expressing defined cDNAs. Nature 411 6833 (2001) 107-110
10. Mousses S., Caplen N.J., Cornelison R., Weaver D., Basik M., Hautaniemi S., et al. RNAi microarray analysis in cultured mammalian cells. Genome Res 13 10 (2003) 2341-2347
11. Delehanty J.B., Shaffer K.M., and Lin B. Transfected cell microarrays for the expression of membrane-displayed single-chain antibodies. Anal Chem 76 24 (2004) 7323-7328
12. Bonadio J., Smiley E., Patil P., and Goldstein S. Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat Med 5 7 (1999) 753-759
13. Bolliet C., Bohn M.C., and Spector M. Non-viral delivery of the gene for glial cell line-derived neurotrophic factor to mesenchymal stem cells in vitro via a collagen scaffold. Tissue Eng Part C Methods 14 3 (2008) 207-219
14. Scherer F., Schillinger U., Putz U., Stemberger A., and Plank C. Nonviral vector loaded collagen sponges for sustained gene delivery in vitro and in vivo. J Gene Med 4 6 (2002) 634-643
15. Jang J.H., Rives C.B., and Shea L.D. Plasmid delivery in vivo from porous tissue-engineering scaffolds: transgene expression and cellular transfection. Mol Ther 12 3 (2005) 475-483
16. Kang S.W., Lim H.W., Seo S.W., Jeon O., Lee M., and Kim B.S. Nanosphere-mediated delivery of vascular endothelial growth factor gene for therapeutic angiogenesis in mouse ischemic limbs. Biomaterials 29 8 (2008) 1109-1117
17. Geer D.J., and Andreadis S.T. A novel role of fibrin in epidermal healing: plasminogen-mediated migration and selective detachment of differentiated keratinocytes. J Invest Dermatol 121 5 (2003) 1210-1216
18. Geer D.J., Swartz D.D., and Andreadis S.T. Fibrin promotes migration in a three-dimensional in vitro model of wound regeneration. Tissue Eng 8 5 (2002) 787-798
19. Geer D.J., Swartz D.D., and Andreadis S.T. Biomimetic delivery of keratinocyte growth factor upon cellular demand for accelerated wound healing in vitro and in vivo. Am J Pathol 167 6 (2005) 1575-1586
20. Han B., Schwab I.R., Madsen T.K., and Isseroff R.R. A fibrin-based bioengineered ocular surface with human corneal epithelial stem cells. Cornea 21 5 (2002) 505-510
21. Willerth S.M., Arendas K.J., Gottlieb D.I., and Sakiyama-Elbert S.E. Optimization of fibrin scaffolds for differentiation of murine embryonic stem cells into neural lineage cells. Biomaterials 27 36 (2006) 5990-6003
22. Hankemeier S., Hurschler C., Zeichen J., van Griensven M., Miller B., Meller R., et al. Bone marrow stromal cells in a liquid fibrin matrix improve the healing process of patellar tendon window defects. Tissue Eng Part A (2008) 10.1089/ten.tea.2008.0046
23. Bruns H., Kneser U., Holzhuter S., Roth B., Kluth J., Kaufmann P.M., et al. Injectable liver: a novel approach using fibrin gel as a matrix for culture and intrahepatic transplantation of hepatocytes. Tissue Eng 11 11-12 (2005) 1718-1726
24. Osathanon T., Linnes M.L., Rajachar R.M., Ratner B.D., Somerman M.J., and Giachelli C.M. Microporous nanofibrous fibrin-based scaffolds for bone tissue engineering. Biomaterials 29 30 (2008) 4091-4099
25. Grassl E.D., Oegema T.R., and Tranquillo R.T. Fibrin as an alternative biopolymer to type-I collagen for the fabrication of a media equivalent. J Biomed Mater Res 60 4 (2002) 607-612
26. Grassl E.D., Oegema T.R., and Tranquillo R.T. A fibrin-based arterial media equivalent. J Biomed Mater Res 66A (2003) 550-561
27. Swartz D.D., Russell J.A., and Andreadis S.T. Engineering of fibrin-based functional and implantable small-diameter blood vessels. Am J Physiol Heart Circ Physiol 288 3 (2005) H1451-H1460
28. Liu J.Y., Swartz D.D., Peng H.F., Gugino S.F., Russell J.A., and Andreadis S.T. Functional tissue-engineered blood vessels from bone marrow progenitor cells. Cardiovasc Res 75 3 (2007) 618-628
29. Chung T.W., Yang M.C., and Tsai W.J. A fibrin encapsulated liposomes-in-chitosan matrix (FLCM) for delivering water-soluble drugs: influences of the surface properties of liposomes and the crosslinked fibrin network. Int J Pharm 311 1-2 (2006) 122-129
30. Schense J.C., Bloch J., Aebischer P., and Hubbell J.A. Enzymatic incorporation of bioactive peptides into fibrin matrices enhances neurite extension. Nat Biotechnol 18 4 (2000) 415-419
31. Zisch A.H., Lutolf M.P., Ehrbar M., Raeber G.P., Rizzi S.C., Davies N., et al. Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth. FASEB J 17 15 (2003) 2260-2262
32. Zisch A.H., Schenk U., Schense J.C., Sakiyama-Elbert S.E., and Hubbell J.A. Covalently conjugated VEGF-fibrin matrices for endothelialization. J Control Release 72 1-3 (2001) 101-113
33. Sakiyama-Elbert S.E., and Hubbell J.A. Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix. J Control Release 69 1 (2000) 149-158
34. Sakiyama-Elbert S.E., Panitch A., and Hubbell J.A. Development of growth factor fusion proteins for cell-triggered drug delivery. FASEB J 15 7 (2001) 1300-1302
35. Andree C., Voigt M., Wenger A., Erichsen T., Bittner K., Schaefer D., et al. Plasmid gene delivery to human keratinocytes through a fibrin-mediated transfection system. Tissue Eng 7 6 (2001) 757-766
36. Christman K.L., Fang Q., Yee M.S., Johnson K.R., Sievers R.E., and Lee R.J. Enhanced neovasculature formation in ischemic myocardium following delivery of pleiotrophin plasmid in a biopolymer. Biomaterials 26 10 (2005) 1139-1144
37. Breen A.M., Dockery P., O'Brien T., and Pandit A.S. The use of therapeutic gene eNOS delivered via a fibrin scaffold enhances wound healing in a compromised wound model. Biomaterials 29 21 (2008) 3143-3151
38. Escamez M.J., Carretero M., Garcia M., Martinez-Santamaria L., Mirones I., Duarte B., et al. Assessment of optimal virus-mediated growth factor gene delivery for human cutaneous wound healing enhancement. J Invest Dermatol 128 6 (2008) 1565-1575
39. Trentin D., Hubbell J., and Hall H. Non-viral gene delivery for local and controlled DNA release. J Control Release 102 1 (2005) 263-275
40. Trentin D., Hall H., Wechsler S., and Hubbell J.A. Peptide-matrix-mediated gene transfer of an oxygen-insensitive hypoxia-inducible factor-1alpha variant for local induction of angiogenesis. Proc Natl Acad Sci U S A 103 8 (2006) 2506-2511
41. Schillinger U., Wexel G., Hacker C., Kullmer M., Koch C., Gerg M., et al. A fibrin glue composition as carrier for nucleic acid vectors. Pharm Res 25 12 (2008) 2946-2962
42. Saul J.M., Linnes M.P., Ratner B.D., Giachelli C.M., and Pun S.H. Delivery of non-viral gene carriers from sphere-templated fibrin scaffolds for sustained transgene expression. Biomaterials 28 31 (2007) 4705-4716
43. Bannasch H., Fohn M., Unterberg T., Bach A.D., Weyand B., and Stark G.B. Skin tissue engineering. Clin Plast Surg 30 4 (2003) 573-579
44. Isenberg B.C., Williams C., and Tranquillo R.T. Small-diameter artificial arteries engineered in vitro. Circ Res 98 1 (2006) 25-35
45. Peretti G.M., Xu J.W., Bonassar L.J., Kirchhoff C.H., Yaremchuk M.J., and Randolph M.A. Review of injectable cartilage engineering using fibrin gel in mice and swine models. Tissue Eng 12 5 (2006) 1151-1168
46. Pandit A.S., Wilson D.J., and Feldman D.S. Fibrin scaffold as an effective vehicle for the delivery of acidic fibroblast growth factor (FGF-1). J Biomater Appl 14 3 (2000) 229-242
47. Sakiyama S.E., Schense J.C., and Hubbell J.A. Incorporation of heparin-binding peptides into fibrin gels enhances neurite extension: an example of designer matrices in tissue engineering. FASEB J 13 15 (1999) 2214-2224
48. Kongkaneramit L., Sarisuta N., Azad N., Lu Y., Iyer A.K., Wang L., et al. Dependence of reactive oxygen species and FLICE inhibitory protein on lipofectamine-induced apoptosis in human lung epithelial cells. J Pharmacol Exp Ther 325 3 (2008) 969-977
49. Yao L., Swartz D.D., Gugino S.F., Russell J.A., and Andreadis S.T. Fibrin-based tissue-engineered blood vessels: differential effects of biomaterial and culture parameters on mechanical strength and vascular reactivity. Tissue Eng 11 7-8 (2005) 991-1003
50. Herbert C.B., Nagaswami C., Bittner G.D., Hubbell J.A., and Weisel J.W. Effects of fibrin micromorphology on neurite growth from dorsal root ganglia cultured in three-dimensional fibrin gels. J Biomed Mater Res 40 4 (1998) 551-559